A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

NCT02050321 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Pharmaceutical company pulled support for the trial.

Conditions

Malignant Melanoma

Interventions

DRUG: Acitretin
DRUG: Vemurafenib

Sponsor

University of Arizona